Povorcitinib
磷酸泊沃昔替尼
Report date: 2026/05/15 20:01:45
NME
Base Information
Drug NamePovorcitinib
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[25]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesIncyte Corp
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesHainan Kangzhe Beauty Technology Co LtdChina Medical System Holdings LtdIncyte Corp +[4]
Inactive CompaniesN/A
Active Indications +[10]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A